{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-26-044734","form_type":"8-K","ticker":"PASG","cik":"0001787297","company_name":"Passage BIO, Inc.","filed_at":"2026-11-18T21:15:33+00:00","discovered_at":"2026-11-18T21:17:00.824232+00:00","generated_at":"2026-11-18T21:17:13.115714+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.62,"calibrated_materiality_score":0.62,"confidence":"high","headline":"Passage Bio gets Nasdaq deficiency notice; stockholders' equity $50K vs $2.5M minimum","bullets":["Nasdaq Rule 5550(b)(1) requires $2.5M minimum stockholders' equity; Passage Bio reported $50,000 at Sept 30, 2026 and fails the market-value and net-income alternatives.","Letter from Nasdaq Listing Qualifications dated Nov 12, 2026 has no immediate effect; PASG continues trading on the Nasdaq Capital Market.","Company expects the pending Remix Therapeutics mergers (A&R agreement dated Sept 2, 2026, amended Oct 5, 2026) to restore compliance on close.","Upon closing, Passage Bio will rename itself Remix Therapeutics, Inc. and trade under symbol RMTX; Nasdaq listing approval is a remaining closing condition.","If the mergers are not completed within the Nasdaq-provided period, the company intends to submit a plan to regain compliance."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-044734","json":"https://secwatch.observer/filing/0001140361-26-044734.json","markdown":"https://secwatch.observer/filing/0001140361-26-044734.md","text":"https://secwatch.observer/filing/0001140361-26-044734.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1787297/000114036126044734/0001140361-26-044734-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1787297/000114036126044734/ef20085890_8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-11-18T21:17:13.115714+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}